IL6 and colorectal cancer: It has been found that activation of autophagy via IL-6/JAK2/beclin 1 pathway in colorectal cancer [221] in turn facilitates IL-6 secretion by secretory autophagy to promote tumor development and chemotherapy resistance (Center, Fig. 6).